Position in JNJ
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$5,510,895
+$140,549 QoQ
Shares Held
21,699
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.91%
of 13F equity value
Holder Rank
#1,553
of 4,676 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026St. Clair Advisors, LLC holds $10,019,901 across 6 Drug Manufacturers - General names. JNJ ranks #1 (55.0% of the industry book) .
All Filings in JNJ
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,510,895 | 21,699 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $5,370,346 | 21,970 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $4,546,691 | 21,970 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,980,967 | 21,470 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $3,288,402 | 21,528 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $3,560,584 | 21,470 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $3,104,991 | 21,470 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,424,651 | 21,132 | Shares | Sole | 2025-04-10 | |
| 2024-06-30 | $3,088,653 | 21,132 | Shares | Sole | 2025-04-10 | |
| 2024-03-31 | $3,342,871 | 21,132 | Shares | Sole | 2025-04-10 | |
| 2023-12-31 | $3,169,909 | 20,224 | Shares | Sole | 2025-04-10 | |
| 2023-09-30 | $3,149,888 | 20,224 | Shares | Sole | 2025-04-10 | |
| 2023-06-30 | $3,347,476 | 20,224 | Shares | Sole | 2025-04-10 | |
| 2023-03-31 | $2,698,085 | 17,407 | Shares | Sole | 2025-04-10 | |
| 2022-12-31 | $1,256,334 | 7,112 | Shares | Sole | 2025-04-10 | |
| 2021-09-30 | $208,335 | 1,290 | Shares | Sole | 2025-04-10 | |
| No filing history on record for this holder in this stock. | ||||||